- Home
- EMN vs BIRK Comparison
EMN vs BIRK Comparison
Compare EMN & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EMN | BIRK |
|---|---|---|
| Founded | 1920 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.9B |
| IPO Year | 1996 | 2023 |
Fundamental Metrics
Financial Performance| Metric | EMN | BIRK |
|---|---|---|
| Price | $75.27 | $42.39 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $78.57 | $62.69 |
| AVG Volume (30 Days) | 1.6M | ★ 2.5M |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.45% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.10 | N/A |
| Revenue | ★ $8,752,000,000.00 | N/A |
| Revenue This Year | $1.75 | $13.71 |
| Revenue Next Year | $3.32 | $13.88 |
| P/E Ratio | $18.41 | ★ $17.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $56.11 | $36.45 |
| 52 Week High | $99.89 | $57.39 |
Technical Indicators
Market Signals| Indicator | EMN | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 59.62 |
| Support Level | $74.55 | $40.55 |
| Resistance Level | $82.30 | $44.92 |
| Average True Range (ATR) | 2.69 | 1.70 |
| MACD | -0.87 | 0.35 |
| Stochastic Oscillator | 31.61 | 95.63 |
Price Performance
Historical ComparisonAbout EMN Eastman Chemical Company
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
About BIRK Birkenstock Holding plc
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.